Product Details for ANDA 040159
MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)
2.5MG
Marketing Status: Prescription
5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
2.5MG
Marketing Status: Prescription
Active Ingredient: MEDROXYPROGESTERONE ACETATE
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040159
Product Number: 001
Approval Date: Aug 9, 1996
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040159
Product Number: 001
Approval Date: Aug 9, 1996
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
5MG
Marketing Status: Prescription
Active Ingredient: MEDROXYPROGESTERONE ACETATE
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040159
Product Number: 002
Approval Date: Aug 9, 1996
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040159
Product Number: 002
Approval Date: Aug 9, 1996
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: MEDROXYPROGESTERONE ACETATE
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040159
Product Number: 003
Approval Date: Aug 9, 1996
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040159
Product Number: 003
Approval Date: Aug 9, 1996
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information